Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,320 INR | +0.81% | +0.83% | -2.67% |
May. 24 | Caplin Point Arm Gets US FDA's Nod for Phenylephrine Hydrochloride Ophthalmic Solution | MT |
May. 16 | Caplin Point Laboratories to Seek Acquisitions | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-2.67% | 1.18B | |
+17.43% | 42.25B | |
+17.28% | 21.27B | |
+16.67% | 15.23B | |
+19.84% | 14.36B | |
+51.59% | 12.74B | |
-0.05% | 6.79B | |
-11.90% | 6.61B | |
-8.87% | 5.73B | |
+14.28% | 5.66B |
- Stock Market
- Equities
- 524742 Stock
- News Caplin Point Laboratories Limited
- Transcript : Caplin Point Laboratories Limited, Q1 2022 Earnings Call, Aug 06, 2021